M&A
NA
FY25
Exclusive financial advisor to India’s leading FMCG company, on its acquisition of Sesa Care Private Limited through a merger
Ambit acted as the exclusive financial advisor to India’s leading FMCG company, on its acquisition of Sesa Care Private Limited through a merger along with its foreign wholly owned subsidiary
Exclusive financial advisor to India’s leading FMCG company, on its acquisition of Sesa Care Private Limited through a merger
Ambit acted as the exclusive financial advisor to India’s leading FMCG company, on its acquisition of Sesa Care Private Limited through a merger along with its foreign wholly owned subsidiary
M&A
INR 28.4 bn
FY25
Sale of a portfolio of 7 road assets to Cube InvIT by Cube Highways and Infrastructure III Pte Ltd.
Ambit acted as an exclusive financial advisor to Cube Highways and Infrastructure III Pte Ltd. on their 100% stake sale in seven road assets to Cube Highways Trust (“Cube InvIT”).
Sale of a portfolio of 7 road assets to Cube InvIT by Cube Highways and Infrastructure III Pte Ltd.
Ambit acted as an exclusive financial advisor to Cube Highways and Infrastructure III Pte Ltd. on their 100% stake sale in seven road assets to Cube Highways Trust (“Cube InvIT”).
ECM
INR 4 bn
FY25
Left Lead BRLM for QIP of Sundaram-Clayton Limited
Ambit acted as the Left Lead BRLM to INR 4 bn QIP of Sundaram-Clayton Limited. Ambit spearheaded the entire process including documentation and marketing, ensuring a seamless and efficient execution of the transaction in a quick timeframe of ~6 weeks.
Left Lead BRLM for QIP of Sundaram-Clayton Limited
Ambit acted as the Left Lead BRLM to INR 4 bn QIP of Sundaram-Clayton Limited. Ambit spearheaded the entire process including documentation and marketing, ensuring a seamless and efficient execution of the transaction in a quick timeframe of ~6 weeks.
Capital Raise
USD 20 mn
FY25
Exclusive advisor to Orbicular Pharmaceutical Technologies Pvt. Ltd. Technologies on its growth capital fund raise
Ambit acted as the exclusive financial advisor to Orbicular on its growth capital fund raise of USD 20 Mn led by Tata Capital Healthcare Fund
Exclusive advisor to Orbicular Pharmaceutical Technologies Pvt. Ltd. Technologies on its growth capital fund raise
Ambit acted as the exclusive financial advisor to Orbicular on its growth capital fund raise of USD 20 Mn led by Tata Capital Healthcare Fund
M&A
INR 17.5 bn
FY25
Financial Advisor to Indostar Capital Finance on sale of its subsidiary, Indostar Home Finance, to EQT
(Signed)
Ambit acted as the financial advisor to IndoStar Capital Finance Ltd. on the sale of its housing finance subsidiary, IndoStar Home Finance Private Limited, to EQT for INR 1,750 Cr.
The transaction is subject to customary consents and approvals. Further, EQT plans to invest INR 500 Cr into Indostar Home Finance upon or shortly after closing of this transaction.
Financial Advisor to Indostar Capital Finance on sale of its subsidiary, Indostar Home Finance, to EQT
(Signed)
Ambit acted as the financial advisor to IndoStar Capital Finance Ltd. on the sale of its housing finance subsidiary, IndoStar Home Finance Private Limited, to EQT for INR 1,750 Cr.
The transaction is subject to customary consents and approvals. Further, EQT plans to invest INR 500 Cr into Indostar Home Finance upon or shortly after closing of this transaction.
M&A
INR 27 bn
FY25
Sale of Investor stake in L&T Infrastructure Development Projects Limited (L&T IDPL)
Ambit acted as the sole and exclusive financial adviser to CPP Investments for sale of their 49% stake in L&T Infrastructure Development Projects Limited (L&T IDPL) to portfolio company of a fund managed by Edelweiss Alternative Asset Advisors Limited
Sale of Investor stake in L&T Infrastructure Development Projects Limited (L&T IDPL)
Ambit acted as the sole and exclusive financial adviser to CPP Investments for sale of their 49% stake in L&T Infrastructure Development Projects Limited (L&T IDPL) to portfolio company of a fund managed by Edelweiss Alternative Asset Advisors Limited
M&A
USD 400 mn
FY25
Ambit facilitated the acquisition of a controlling stake by KKR in HCG
Ambit facilitated KKR's acquisition of a controlling stake in HCG for c. $400 mn
Ambit facilitated the acquisition of a controlling stake by KKR in HCG
Ambit facilitated KKR's acquisition of a controlling stake in HCG for c. $400 mn
ECM
INR 8 bn
FY25
Book Running Lead Manager for QIP of Max Estates
Ambit was the Book Running Lead Manager for INR 8 bn QIP of Max Estates Limited. Ambit's strategic marketing and continuous investor education attracted a broad spectrum of domestic and global investors, culminating in a successful transaction.
Book Running Lead Manager for QIP of Max Estates
Ambit was the Book Running Lead Manager for INR 8 bn QIP of Max Estates Limited. Ambit's strategic marketing and continuous investor education attracted a broad spectrum of domestic and global investors, culminating in a successful transaction.
M&A
INR 45 bn
FY25
Ambit acted as the Exclusive Financial Advisor on sale of 100% stake by Poonawalla Group and Others to Patanjali Ayurved and DS Group
(Signed)
Ambit acted as the Exclusive Financial Advisor on sale of 100% stake in Magma General Insurance by Sanoti Properties (a Poonawalla Group entity) and Other shareholders to Patanjali Ayurved and DS Group for INR 45 Bn
(Signed)
Ambit acted as the Exclusive Financial Advisor on sale of 100% stake by Poonawalla Group and Others to Patanjali Ayurved and DS Group
(Signed)
Ambit acted as the Exclusive Financial Advisor on sale of 100% stake in Magma General Insurance by Sanoti Properties (a Poonawalla Group entity) and Other shareholders to Patanjali Ayurved and DS Group for INR 45 Bn
(Signed)